## **Core Concept**
The patient presents with hypertension (BP 150/100 mmHg) and proteinuria (2+), which are key diagnostic criteria for preeclampsia, a pregnancy complication characterized by new-onset hypertension and often accompanied by significant proteinuria after 20 weeks of gestation. The management of preeclampsia involves careful consideration of both maternal and fetal well-being.

## **Why the Correct Answer is Right**
The first-line drug of choice for managing hypertension in preeclampsia, particularly in a pregnant woman at 32 weeks gestation, is often a medication that effectively lowers blood pressure while minimizing risks to the fetus. **Methyldopa** is commonly used as a first-line agent because it has a long history of safe use in pregnancy, although its efficacy can vary. Other options like labetalol and nifedipine are also frequently used, but **methyldopa** has been a traditional first-line choice due to its safety profile.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While labetalol is a popular choice for managing hypertension in pregnancy, including preeclampsia, due to its effectiveness and safety profile, it is not universally considered the first-line treatment over methyldopa.
- **Option B:** Nifedipine can be used for acute blood pressure control in pregnancy but might not be the immediate first choice for chronic management of hypertension in preeclampsia compared to methyldopa.
- **Option D:** This option is not provided, but typically, drugs like atenolol are less favored in pregnancy due to concerns about fetal growth restriction.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the goal of antihypertensive therapy in preeclampsia is not necessarily to normalize blood pressure but to prevent complications such as stroke and to allow for safe prolongation of pregnancy to improve fetal outcomes. Additionally, it's crucial to monitor both maternal and fetal well-being closely.

## **Correct Answer:** . **Methyldopa**